EXAS - Exact Sciences announces debt exchange transaction April, 11 2024 03:05 PM Exact Sciences Corporation 2024-04-11 15:05:51 ET More on Exact Sciences Exact Sciences: Cancer Battle Continues, Shares Likely To Plateau Exact Sciences gains after data for novel cancer screening test Exact Sciences GAAP EPS of -$0.27 beats by $0.21, revenue of $647M beats by $7.3M For further details see: Exact Sciences announces debt exchange transaction